Anti-CTLA4 (Ipilimumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC Preis auf Anfrage

Produktübersicht

• Artikelname: Anti-CTLA4 (Ipilimumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC Preis auf Anfrage
• Artikelnummer: CRB-ADC-W-1003-1UNIT
• Hersteller Artikelnummer: ADC-W-1003
• Alternativnummer: CRB-ADC-W-1003-1UNIT
• Hersteller: Creative Biolabs
• Kategorie: Antikörper

Produktbeschreibung

This ADC product is comprised of an anti-CTLA4 monoclonal antibody conjugated via a MC-Vc-PAB-DMEA-(PEG2) linker to duocarmycin SA. The duocarmycin SA is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediat